|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents ($113,128 and $165,771 related to variable interest entities (VIEs)) | ||||||||||||||||||||
| Accounts receivable, net ($24,773 and $42,288 related to VIEs) | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Costs and estimated earnings in excess of billings ($183,988 and $42,997 related to VIEs) | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Assets held for sale (Note 10) | ||||||||||||||||||||
| Other current assets ($103,456 and $163,810 related to VIEs) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Equity investments | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Deferred income taxes (Note 17) | ||||||||||||||||||||
| Non-current assets of discontinued operations (Note 5) | ||||||||||||||||||||
| Other non-current assets ($128,541 and $74,067 related to VIEs) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Revolving facility and other short-term borrowings | ||||||||||||||||||||
| Current maturities of long-term debt, net | ||||||||||||||||||||
| Accounts payable ($382,616 and $348,872 related to VIEs) | ||||||||||||||||||||
| Billings in excess of costs and estimated earnings ($48,970 and $130,484 related to VIEs) | ||||||||||||||||||||
| Current liabilities of discontinued operations (Note 5) | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net (Note 11) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Non-current liabilities of discontinued operations (Note 5) | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (Note 14) | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common stock, Euro .01 par value; shares authorized: 250,000; shares issued: 108,857 and 108,857; shares outstanding: 102,547 and 101,705 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Treasury stock, at cost: 6,310 and 7,152 shares | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total CB&I shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
